INTRODUCTION
============

As a result of the indiscriminate use of antimicrobial drugs in the treatment of infectious diseases, microorganisms have developed resistance to many antibiotics \[[@R1]\]. Recently, methicillin-resistant *Staphylococcus aureus* (MRSA), *Escherichia coli* O157:H7, *Mycobacterium tuberculosis*, and *Pseudomonas aeruginosa* are considered some of the most virulent microorganisms for the human population \[[@R2]\]. Therefore, there is a critical need to move fast and develop alternative antimicrobial drugs. One approach is to screen local medicinal plants which represent a rich source of novel antimicrobial agents. Medicinal plants are an integral component of research development in microbiology and pharmaceutical industry. Natural products from plants have traditionally provided the pharmaceutical industry with one of its most important sources of lead compounds; up to 40% of modern drugs are derived from natural sources using either natural substances or synthesized versions \[[@R3]\].

Flavonoids have been shown to be associated with many of biological effects such as antibacterial, antiviral, anti-inflammatory, antiplatelet, antioxidant, free radical scavenging, and vasodilatory actions \[[@R4]\]. High activity of flavonoids and antioxidant was found in intensely colored vegetables, such as red cabbage, red onion, etc. \[[@R5]\] rendering them as likely sources of novel antimicrobial activities that in the future might lead to a breakthrough discovery of new antibiotics or antifungal drugs. On the other hand, synthetic chemicals have long been used as active agents in reducing the incidence of diseases in plants, animals and humans; however, these drugs are not cheap and takes a lot of effort to produce \[[@R1]\]. Therefore, there is a need to search more on new resources such as medicinal plants. Medicinal plants have become very necessary to provide the society with cheap and even effective medical alternative drugs. Such medicinal plant products are believed to be highly crucial to improve the society health level and prevent the development of serious diseases \[[@R6]\].

Red cabbage (*Brassica oleracea* L. var. *capitata* f. *rubra* DC), which belongs to the family Brassicaceae is one of the most important vegetables grown worldwide \[[@R7]\]. Recently, red cabbage has attracted much attention because of its physiological functions and applications. There were some studies conducted on red cabbage extract proving its anticancer \[[@R8], [@R9]\], anti-inflammatory \[[@R10]\], anti-diabetic effects \[[@R11]\]. However, only two studies for its antibacterial effects were done worldwide \[[@R12], [@R13]\].

To the best of our knowledge, there was no previous study covered the antimicrobial effect of the red cabbage extract against *E. coli* O157:H7, MRSA, *Staphylococcus aureus*, *Salmonella enterica* serovar Typhimurium, *Pseudomonas aeruginosa,* and *Klebsiella pneumoniae.* This study was also carried out to explore, for the first time, the antifungal effect of red cabbage methanol crude extract against 10 different fungal species. This study is believed to be the cornerstone for further development with regards to red cabbage extract to specify exactly the antibacterial and antifungal compounds and their mechanism of action.

MATERIALS AND METHODS
=====================

Plant Material and Preparation of the Extract
---------------------------------------------

Fresh red cabbage was purchased from local markets in the state of Selangor, Malaysia. The cabbage leaves were chopped into small pieces and left to dry at room temperature in dark area for approximately 7 days. After drying the leaves were ground to powder. The ground powder was extracted 1:10, wt/v with 2.4 mol/L HCl acidified methanol (Merck, Darmstadt, Germany) to extract all phenolic compounds, free and conjugated \[[@R14]\] and soaked for three days in dark at room temperature. The solvent was then removed by filtration and fresh solvent was then added to the plant material. The extraction procedure was repeated twice and extracts were combined and evaporated to dryness under vacuum at 40°C. The pH of red cabbage leaves extract ranged from 6.8 to 7.2 which is a neutral pH. The powder was stored at -18°C.

Microorganisms and Media
------------------------

A total of 22 microorganisms consisting of 12 bacteria and 10 fungi were used in this study (Table **[1](#T1){ref-type="table"}** and **[3](#T3){ref-type="table"}**). All of the microorganisms were obtained from the microbiology laboratory of the Institute of Bioscience, University Putra Malaysia. Bacteria, other than ATCC strains, were identified by the use of biochemical profiles according to the recommendations of the manual of clinical microbiology \[[@R15]\] while fungi, other than ATCC strains, were identified depending on the macro- and micro- scopic features \[[@R16]\]. The tested bacteria and fungi were maintained on nutrient agar (Merck, Darmstadt, Germany) and sabouraud dextrose agar slants (Merck, Darmstadt, Germany), respectively, at 4°C until further use.

The tested bacteria were subjected to a panel of antibiotic susceptibility discs (BBL, USA) for profiling their antibiotic sensitivity. Out of 12 tested bacteria, three multiple drug resistant (MDR) bacteria were found. The MDR bacteria were MRSA, *P. aeruginosa*, and Enterohemorrhagic (EHEC) *E. coli* O157:H7 which were highly resistant to more than four antibiotics. Isolates other than MDR and ATCC strains were either resistant to one antibiotic or not resistant to any of the tested antibiotics. MRSA isolate was completely resistant to oxacillin, erythromycin, streptomycin, clindamycin and tetracycline. Moreover, the MRSA isolate was a bit borderline resistant to vancomycin, namely vancomycin-intermediate *Staphylococcus aureus* (VISA). The MDR *P. aeruginosa* isolate was resistant to ceftazidime, ciprofloxacin, cefepime, imipenem, and piperacillin/tazobactam. The MDR *E. coli* O157:H7 isolate was resistant to ampicillin, kanamycin, sulfisoxazole, and tetracycline. Therefore, nine non-MDR and three MDR bacteria were used to test the antibacterial effect of red cabbage leaves extract.

ANTIMICROBIAL SENSITIVITY TESTS
===============================

Disc Diffusion Assay
--------------------

The dried plant extracts were dissolved in the same solvent, methanol, to final concentrations of 200 and 500 mg/ml for antibacterial tests and 200, 500 and 700 mg/ml for antifungal tests and were sterilized by filtration through 0.45 µm Millipore filters (Nalgene, UK). The primary screening antimicrobial test was carried out by disc diffusion \[[@R15]\] using 100 µl of suspension containing 10^8^ CFU/ml of bacteria and 10^5^ spore/ml of fungi, spread evenly on the surface of the nutrient agar and sabouraud dextrose agar plates, respectively. Sterile Whatman No. 1 filter paper (MACHEREY-NAGEL, MN 615, Germany) was used to prepare 6 mm in diameter discs. These discs were processed, in triplicates, to contain 10 µl of the extract, i.e.; (2mg/disc), (5mg/disc) and (7mg/disc) for extract concentrations (200 mg/ml), (500 mg/ml) and (700 mg/ml), respectively; these discs were then impregnated in the inoculated agar. Negative controls were prepared, in triplicates per Petri dish, using the same solvents employed to dissolve the plant extracts. Ten µg/disc of Streptomycin (CALBIOCHEM, China) and Amphotericin B (Sigma, Steinheim, Germany) were used, in triplicates per Petri dish, as positive controls or reference standard drugs for comparing the sensitivity of tested bacteria and fungi, respectively, with the test extract. For bacteria, the inoculated plates were incubated for 24 h at 37°C and, for fungi, the inoculated plates were incubated for 3-5 days at 30-35°C. Clear inhibition zones around discs indicated the presence of antimicrobial activity. For optimal fidelity of results, each assay was repeated three times.

Microdilution Assay
-------------------

The minimum inhibitory concentration (MIC) values were also studied for the microorganisms found sensitive to the extract by using disc diffusion assay. The MIC is defined as the lowest concentration of the compounds to inhibit the growth of microorganisms. The microdilution method was used according to the methodology referred by \[[@R17]\] with some modifications. The inocula of bacteria were prepared from 12 h broth cultures and standardized to 10^8^ CFU/ml. And fungal inocula were prepared from 3-5 days fresh fungal cultures, depending on the fungus type, and standardized to 10^5^ spore/ml. Stock extracts of 1200 and 700 mg/ml concentrations were prepared in 10% dimethylsulfoxide (Merck, Darmstadt, Germany) for bacterial and fungal tests, respectively. Serial dilutions of the stock extract solutions were prepared in concentrations range from 0 to 600 mg/ml for bacteria and 0 to 350 mg/ml for fungi. For bacteria, the extract solution was diluted using nutrient broth (Merck, Darmstadt, Germany) and, for fungi, the extract solution was diluted in sabouraud dextrose broth (Merck, Darmstadt, Germany). One hundred microlitter of the stock extract was transferred to each of the first three wells of the first column to prepare the first extract dilution then 100 μl/well of each microorganism suspension were dispensed into 96-well flat-bottom microtiter plate (Steriline, UK). From the first column, 100 *µ*l from each well was transferred to the wells of the next column to prepare the second extract dilution with 100 µl/well of the microorganism. The rest of the extract dilutions were prepared by the same method. On the other hand, triplicates of extract-free bacterial and fungal spore suspensions were used as negative controls as well as triplicates of streptomycin at concentration range of (0.02-1 µg/ml) and amphotericin B at concentration range of (0.5-3 µg/ml) were used as standard antibacterial and antifungal positive controls. The final volume in each well was 200 µl. The plate was covered with a sterile plate sealer 80/140mm (Greiner bio-one, Germany). For bacteria, plates were incubated for 24 h at 37°C while for fungi; plates were incubated for 3-5 days at 30-35°C. The growth of bacteria and fungi was determined by absorbance values at 600 nm and 530 nm respectively using fully automated Microplate Spectrophotometer (Bio-Rad Laboratories, Hercules, Canada).

To confirm MIC and to establish minimum bactericidal (MBC) and minimum fungicidal (MFC) concentrations, 10µl of each culture medium for bacteria and fungi with no visible growth were removed from each well and inoculated, in triplicates, on nutrient agar and sabouraud dextrose agar plates, respectively. After incubation for 24 h at 37°C, for bacteria, and 3-5 days at 30-35°C, for fungi, the number of surviving organisms was determined. MBC and MFC are defined as the lowest extract concentration at which 99.9% of the microorganism is killed. The extract tested in this study was screened three times for each organism.

Scanning Electron Microscope (SEM) and Transmission Electron Microscope (TEM) Observations
------------------------------------------------------------------------------------------

Scanning electron microscope observations were carried out on *S. aureus* (ATCC 29247) and *E.coli* (ATCC 25922) as an example for the extract effect on bacterial cells of Gram negative and Gram positive bacteria. One milliliter of 10^8^ CFU/ml of *S.aureus* or *E.coli* bacterial suspensions were incubated with the extract at concentraion of 100 mg/ml for 24 h at 37°C. A 10% DMSO-treated culture was used as a negative control. The control and the extract treated cells were fixed in 4% glutaraldehyde (Sigma, Steinheim, Germany) and later postfixed in 1% osmium tetraoxide (Sigma, Steinheim, Germany) and they were later washed by 0.1M sodium cacodylate buffer, pH 7.4 (Sigma, Steinheim, Germany). After eliminating the remaining osmium tetraoxide, the samples were dehydrated in a graduated acetone (Merck, Darmstadt, Germany) series (35 to 100%). Each step was performed for about 10 to 15 min at room temperature.

The specimens were then dried in the critical dryer (Baltec, CPD 030). The dried specimens were mounted onto stubs by double-sided carbon tape. The specimens were coated with a thin layer of gold by a Polaron SC 502 sputter coater, and were examined in the Scanning Electron Microscope (Philips, XL30 ESEM).

For the transmission electron microscope observation, after the dehydration step, the fixed cells were embedded with Epon and the small blocks of bacteria were cut with an ultramicrotome (Reichert Jung Ultracut-S, Leica). The ultra thin sections were then analyzed using TEM (Philips, EM400 HMG).

Statistical Analysis
--------------------

The disc diffusion assay was conducted in triplicates in three independent experiments. Therefore, the inhibition zone was expressed as mean SD. SPSS software version 12.0.0.2 was used.

RESULTS
=======

Disc Diffusion Assay for Bacteria
---------------------------------

Qualitative and quantitative results were obtained by the inhibition zone and zone diameter, respectively (Table **[1](#T1){ref-type="table"}**). The methanol extract of *B. oleracea* showed significant inhibitory effect against the growth of both Gram negative and Gram positive bacteria. The mean inhibition zone for the Gram positive bacteria ranged from 7 to 17 mm indicating a remarkable antibacterial effect when compared with that of streptomycin, the positive control, which ranged from 0 to 18 mm. Interestingly, the methanol crude extract for *B. oleracea* exerted an exclusive antibacterial effect against the problematic bacteria MRSA while, interestingly, the anti-bacterial effect of the positive control, streptomycin, was zero. In contrast to all previous studies known in the field of antibacterial natural products, the methanol crude extract of *B. oleracea* in the current study revealed highly significant antibacterial effect against the entire tested Gram negative bacteria (12-20 mm zone of inhibition) whereas the standard drug, streptomycin, exhibited zone of inhibition ranged from 11-19 mm only.

Microdilution Assay for Bacteria
--------------------------------

The MIC of the Gram positive bacteria was 100 mg/ml, including MRSA, while the confirmatory test, MBC, was 400 mg/ml except for *B. subtilis*was 200 mg/ml (Table **[2](#T2){ref-type="table"}**). On the other hand, the MIC of the Gram negative bacteria was between 100-400 mg/ml while the confirmatory test, MBC, was between 200-500 mg/ml (Table **[2](#T2){ref-type="table"}**). The logarithmic OD values were demonstrated for each tested bacterium. OD values decreased in a dose dependent manner reflecting the decrease took place in the bacterial growth (Fig. **[1](#F1){ref-type="fig"}** & **[2](#F2){ref-type="fig"}**). The findings of the MIC and MBC were in agreement with the findings obtained by the primary screening test, disc diffusion assay. Hence, disc diffusion, MIC, and MBC assays together provided evidence that the *B. oleracea* extract was highly effective as antimicrobial agent against both the tested Gram negative and positive bacteria.

Antimicrobial Assays for Fungi
------------------------------

In contrast to the effective antibacterial activity revealed by the crude methanol extract of red cabbage leaves, the extract did not demonstrate effective antifungal activity against most of the tested fungi. Nevertheless, the extract showed an unprecedented potent antifungal activity against two of important human fungal pathogens namely, *T. rubrum* \[[@R18]\] and *A. terreus* \[[@R19]\] at concentrations (700 mg/ml) and (500, 700 mg/ml) respectively (Table **[3](#T3){ref-type="table"}**). The extract under these two concentrations showed clear zone of inhibition. To confirm the antifungal activity, both MIC and MFC were done which confirmed the antifungal activity against these two fungi. The MIC of the extract against *T. rubrum*and *A. terreus* was 75 mg/ml while the MBC of the extract was 300 and 150 mg/ml, respectively (Table **[4](#T4){ref-type="table"}**). The growth inhibition was dose dependent and was reflected by the decrease of OD values which were demonstrated in logarithmic manner (Fig. **[3](#F3){ref-type="fig"}**).

Mode of Antimicrobial Action
----------------------------

The nature of the antibacterial effect of the extract with regard to inhibition/killing of tested bacteria is important. The MBC: MIC ratio for bacteria or MFC: MIC for fungi is used to specify the nature of the antimicrobial effect against any given pathogen \[[@R20]\]. When the MBC: MIC or MFC: MIC ratio of a pathogen is between 1:1 to 2:1, the chemical substance is considered as bactericidal or fungicidal against that pathogen \[[@R20]\]. On the other hand, if the ratio was \> 2:1, the mode of antimicrobial action is more likely to be bacteristatic or fungistatic. Therefore, MBC: MIC or MFC: MIC ratio was calculated for each bacterial or fungal pathogen, respectively. It was found that the tested extract of red cabbage exerted a clear bactericidal effect against 6 isolates of bacteria while it exerted bacteristatic effect against 5 isolates only (Table **[2](#T2){ref-type="table"}**). For fungi, the extract exerted fungicidal effect against *A. terreus* and fungistatic against *T. rubrum* (Table **[4](#T4){ref-type="table"}**).

SEM and TEM Electron Microscope Observations
--------------------------------------------

The antibacterial effect of red cabbage extract on *S. aureus* and *E. coli* was seen clearly by SEM. After exposing *S. aureus* and *E. coli* to 100 mg/ml of the methanol extract, the cells were collapsed and became sticky, almost seen like a shrunken cells when compared to control cells (Fig. **[4](#F4){ref-type="fig"}**). In addition, detachment of the cell membrane of the tested bacterial cells was seen in response to the added red cabbage extract. Therefore, the antibacterial effect of red cabbage extract, observed by TEM, was demonstrated as clear morphorlogical changes in the treated cells (Fig. **[5](#F5){ref-type="fig"}**).

DISCUSSION
==========

The wide spread of MDR microbes raises the need for new, cheap, effective, and safe drugs. One of the best candidates to address this need appears to be the natural resources. Before being considered as a food, cabbage was valued and used for medicinal purposes in treating headache, gout, diarrhea and peptic ulcers \[[@R21]\]. Among the substances that seem to be responsible for these properties are polyphenols \[[@R22]\]. Red cabbage is a rich source of phenolic compounds, mainly anthocyanins which are the most abundant class \[[@R23]\].

Previous studies reported that methanol was the best solvent for the consistent extraction of antimicrobial substances from medicinal plants compared to other solvents such as water, ethanol, or hexane \[[@R24]\]. For this reason, methanol was used in this study to extract the active antimicrobial components from red cabbage leaves. The findings of the current study demonstrated some novel and significant antimicrobial activities against the tested bacteria and fungi. Remarkable zones of inhibition were observed around the discs of the red cabbage extract in nutrient agar plates inoculated with Gram negative (12-20 mm in diameter) and Gram positive bacteria (7-17 mm in diameter). This finding seems to be unique for the current study when compared with previous studies which were conducted to test the antibacterial activity of different natural products. These reports revealed that their extracts were effective against Gram positive rather than Gram negative bacteria and they attributed this variation to the dissimilarity between Gram negative and Gram positive cell walls which makes Gram negative more resistant to many antibacterial agents \[[@R25]\]. This provides evidence that red cabbage extract possesses different antibacterial components exerting different mechanisms of action. The wide spectrum of antibacterial effects of the red cabbage extract in the current study might be attributed to the acid methanol procedure of extraction which is suitable for extracting all fractions efficiently.

In fact, only two studies were found to be conducted on the antibacterial effect of red cabbage extract worldwide. A study done by Lee and his colleagues in 2003 found that red cabbage juice has mild activity against *Staphylococcus epidermidis* but not against *Klebsiella pneumoniae* \[[@R12]\], while Park and his colleagues in 2004 found that the methanol red cabbage fractions seem to be active against *B. subitilis*, *E. coli* and, with mild action, against *P. aeruginosa* \[[@R13]\]. In the current study the effect of red cabbage extract was studied on many bacterial species, including bacteria not researched before such as; *S. aureus*, MRSA, *E. coli* O157:H7, and *Salmonella* *enterica* serovar Typhimurium. Besides, *P. aeruginosa* and *K. pneumoniae* were researched before but, unlike the results of the current study, a study revealed a very mild response and the second one revealed no response at all to red cabbage extract \[[@R12], [@R13]\].

In the current study, the considerable inhibition zone gained from the red cabbage extract at concentration 500 mg/ml against MRSA, 7 mm versus 0 mm of standard drug, and *S. aureus*, about 11 mm versus 17-18 mm of standard drug, was highly promising. The MIC for MRSA and *S. aureus* bacteria was 100 mg/ml while the MBC was 400 mg/ml. Therefore, the MBC: MIC ratio was 4: 1 indicating that the potent anti-MRSA and anti-*S. aureus*effect was more likely bacteristatic in nature. A recent study found that hospitals across the United States and around the world are fighting the escalation of drug-resistant infections \[[@R26]\]. Furthermore, an increase in community-associated methicillin-resistant *Staphylococcus aureus* (CA-MRSA) infections have been reported in many literatures \[[@R27]\]. Most of these infections are severe and life-threatening. Taken into account that the tested MRSA was found of intermediate response to vancomycin (VISA), the antibacterial agent(s) in red cabbage extract responsible for this action must be a top priority for the study and discovery. It is worth mentioning that MRSA--VISA strains present a thickening of the cell wall which is believed to deplete the vancomycin available to kill the bacteria which worries many physicians and microbiologists on the near future prospects of the current anti-MRSA therapies \[[@R28]\]. Furthermore, the current red cabbage anti-MRSA activity and its underlying mechanism of action seem novel and different from other known antibiotics. Accordingly, the discovery of natural, effective, and cheap drug against this resistant bacterium might be considered as a breakthrough solution for this problem all around the world.

Recently, *E. coli* O157:H7 was shown to be highly resistant to different antibiotics which are commonly used by clinicians and veterinarians for the treatment of infections with Gram-negative bacteria \[[@R29]\]. For this reason, the used isolate of EHEC O157:H7 in the current study was selected to be highly resistant isolate against four antibiotics. The antibacterial activity results of the of red cabbage extract against *E.coli* O157:H7 was remarkable. The inhibition zone was about 17 mm at concentration 500 mg/ml of the extract which is only 1 mm less than the diameter of the standard antibiotic, streptomycin. Moreover, the MBC: MIC ratio was 2:1, revealing potent bactericidal effect of red cabbage against this notorious bug. Therefore, the extract of red cabbage can be considered as a novel source of a new candidate antibacterial agent for both human and animal *E. coli* O157:H7 diseases.

For *P. aeruginosa,* it is known to be resistant to high concentrations of salts and dyes, weak antiseptics, and many commonly used antibiotics \[[@R30]\]. The isolate of *P. aeruginosa* used in the current study was selected to be highly resistant against 6 different antibiotics. Despite its bad history in antibiotic sensitivity, interestingly, the red cabbage extract of the current study showed 19 mm inhibition zone which was 1 mm larger than that of streptomycin itself. Moreover, MBC (200): MIC (100) mg/ml, 2:1 ratio, indicated that the red cabbage extract exerted a very potent bactericidal effect at lower concentration of extract than in most other tested bacteria.

For *K. pneumoniae,*it was found that it has developed several strains resistant to several antibiotics. These strains are known as extended-spectrum ß-lactamase (ESBL)-- producing *K. pneumoniae* \[[@R31]\]. Similarly, *Salmonella* *enteric*a serovar Typhimurium began to show serious antimicrobial resistance patterns worldwide *via* ESBL leading to resistance against ampicillin, aminoglycosides, and trimethoprim-sulfamethoxazole \[[@R32]\]. Interestingly, a remarkable antibacterial effect, bacteristatic and bactericidal, was found by the red cabbage extract against *K. pneumoniae* and *S. enterica* serovar Typhimurium. The antibacterial effect of the extract against *S. enterica* serovar Typhimurium was unique in that MBC: MIC ratio was the lowest one among all tested bacteria, 1.25:1. Besides, the inhibition zone was the same for both 200 and 500 mg/ml concentrations of the extract and larger than that of streptomycin. In fact, the 15 mm inhibition zone indicates a very powerful bactericidal effect of red cabbage extract against this bacterium.

Collectively, three MDR bacteria used in the current study were resistant to 15 powerful antibiotics that belong to 8 different groups of antibiotics. These 8 groups belong to 5 common modes of action including cell wall targeting penicillin and 3^rd^ and 4^th^ generations of cephalosporin's, 30S ribosomal subunit targeting glycopeptides and polyketide, 50S ribosomal subunit targeting lincosamide and macrolides, DNA synthesis-inhibiting fluoroquinolones, and enzymes competitors sulfonamides. Since, red cabbage leaves extract exerted a powerful bactericidal effect against two MDR bacteria and exerted a bacteriostatic effect against one MDR bacteria, the antimicrobial effect of the red cabbage leaves extract seems to bypass the most common pathways of antibiotics resistance. Therefore, this provided a clue on the high possibility for the presence of novel antimicrobial compound(s) in red cabbage extract that might not share the same mode of action with the above mentioned antibiotics or at least have some modified interactions of the same pathway.

*A. terreus* infections have become a growing concern in the past few years as a causative agent of invasive aspergillosis \[[@R33]\]. This infection has become resistant to most common antifungal agents used to treat aspergillosis \[[@R34]\]. In addition, *T. rubrum*is the most common dermatophyte species. It is a major concern because feet and nail infections caused by this organism are extremely difficult to cure \[[@R18]\]. In addition, resistance to most of the commercially available antifungal agents was recorded \[[@R35]\]. The use of red cabbage extract in the current study demonstrated significant zones of inhibition in the fungal growth of *T. rubrum*, 8 mm versus 11 mm of standard drug, and *A. terreus*, 11 mm versus 10 mm of standard drug. Hence, it was interesting that the inhibition zone of *A. terreus* by red cabbage extract at concentration 700 mg/ml was larger than that produced by the standard drug. Moreover, the MFC: MIC ratio revealed that red cabbage extract is fungicidal against *A. terreus*, ratio 2: 1, and fungistatic against *T. rubrum*, ratio 4:1. No previous study recorded such antifungal activity of red cabbage extract against any fungi. It was only one study revealed a negative result of the red cabbage extract fraction against *A. oryzae*\[[@R13]\], and it is in confirmatory with the result of this study. Both *T. rubrum*and *A. terreus* are important human pathogens and cause serious health problems all around the world. Therefore, the discovered antifungal effect in this study might be considered as a prelude to discover new antifungal agents to those two problematic pathogenic fungi.

The mixture of phenolic compounds acts synergistically better than its individual components separately \[[@R36]\]. Studies showed that the mixture of anthocyanins (ATH) extracted from red cabbage possessed high antioxidant properties and these studies suggested the presence of the protective action of this extract \[[@R37]\]. This synergistic effect of the phenolic compounds in red cabbage extract, particularly anthocynins mixture, may explain the potent antibacterial action and, for the first time, the significant antifungal action manifested in the current study. Studies revealed that the antioxidant activity of the ATH-rich extract from red cabbage leaves is high, about 33 Trolox equivalents (TE) per g of fresh matter and 328 TE per g of dry matter, whereas, in fruits such as blackberries, cranberries, and strawberries, TE values ranged from 35 to 162 per g of dry matter \[[@R38],[@R39]\]. Taking into account such high antioxidant capacity of the ATH-rich extract from red cabbage leaves, we suppose that the potential antimicrobial activity may be due to this subclass of flavonoids. Interestingly, recent research showed that, through overlapping or complementary effects, the complex mixture of phytochemicals in fruits and vegetables provides a better protective effect on health than single phytochemicals \[[@R40]\]. Therefore, the complex components of red cabbage extract needs to be scrutinized in depth in order to find the best mixture of effective components that had role in the currently shown antibacterial and antifungal actions. This will be necessary to translate the findings of this study into novel commercial antibiotics and antifungal drugs.

Furthermore, one of the interesting points regarding red cabbage leaves extract is its pH range of 6.8 to 7.2. This neutral pH eliminates the possibility that the antimicrobial effect of this extract is attributed to its ability to create an acidic environment. It was proposed that the possible mechanism of antimicrobial activity by some of the phenolic containing extracts is by creating an acidic environment that causes the bacterial cell membrane disruption \[[@R41]\]. Therefore, the substantial results obtained in the current study may be due, in part, to the ATH subclass of flavonoids. Many studies proposed various mechanisms to account for the antioxidant ability of ATH. They include radical scavenging ability, metal chelating property, hydrogen donating ability, complex formation with DNA and direct binding to proteins \[[@R42]-[@R44]\]. These various mechanisms alone or together may attribute to the potent antimicrobial activity we had obtained.

Many studies attempted to investigate the effect of crude plants extracts on different bacteria to support the antibacterial activity they gained from the disc diffusion and the microdilution assays. In this study the electron microscopic observations for both SEM and TEM demonstrated clearly the antibacterial effect of the methanol extract of red cabbage on bacterial cells. There were clear morphological changes with shrunken and collapsed cells of the teated bacteria. This could be due to the leak in the cell wall or perhaps some alteration in the membrane permeability. These findings augmented the antibacterial prospects for the crude methanol extract of the red cabbage which give clue that crude methanol extract of the red cabbagea is a promising antimicrobial agent.

Taken together, it was concluded that the red cabbage extract using acid methanol solvent showed a potent anti-microbial effect against the tested Gram negative, Gram positive bacteria, and fungi. Most interestingly, for the first time, red cabbage extract showed remarkable antibacterial effect against MRSA, *S. aureus*, *E. coli* O157:H7, *S. enterica* serovar Typhimurium, and *K. pneumoniae* as well as remarkable antifungal effect against *T. rubrum* and *A. terreus.* Moreover, the bacterial species that weakly responded to red cabbage extract in previous studies, namely *P. aeruginosa,* were shown to be strongly eradicated by the bactericidal effect of the extract of the current study. This potent effect may be due to the high level of red cabbage active polyphenols, precisely, the anthocyanins. The *in vitro* results of this study on the efficacy of red cabbage crude extract as antimicrobial agent may give confidence about its activity if used *in vivo.* Considering the safety of a natural product extract, red cabbage extract could be a promising antimicrobial agent if used *in vivo.*

CONCLUSION
==========

The findings of the current study unveiled a novel, powerful, and broad spectrum antimicrobial activity of red cabbage leaves extract against a large number of human and animal pathogenic microbes including MDR bacteria, non-MDR bacteria, and fungi. Further investigations on the active antimicrobial components in the red cabbage methanol crude extract are required to provide the pharmaceutical companies with cheap and effective antimicrobial agent.

![The diagrams reflect the decrease in the bacterial growth (**A**: *Staphylococcus aureus* clinical isolate No. 1, **B**: *Staphylococcus aureus* clinical isolate No. 2, **C**: *Staphylococcus aureus* ATCC 29247 and **D**: Methicilline -- resistant *Staphylococcus aureus*) which demonstrated by log10 measured by microdilution assay. The decrease in bacterial growth resulted from red cabbage (RC) methanol crude extract treatment in different concentrations. These four bacteria showed no visible growth around the 6 mm disc impregnated in RC methanol crude extract at 500 mg/ml concentration in the disc diffusion test.](TOMICROJ-5-96_F1){#F1}

![The diagrams reflect the decrease in the bacterial growth (**A**: *Bacillus subtilis*, **B**: *Escherichia coli* clinical isolate, **C**: *Escherichia coli* ATCC 25922, **D**: *Escherichia coli* ATCC 35218, **E**: *Escherichia coli* O157:H7, **F**: *Pseudomonas aeruginosa*, **G**: *Klebsiella pneumoniae* and **H**: *Salmonella enterica* serovar Typhimurium ATCC 25241) which demonstrated by log10 measured by microdilution assay. The decrease in bacterial growth resulted from red cabbage (RC) methanol crude extract treatment in different concentrations. These eight bacteria showed no visible growth around the 6 mm disc impregnated in RC methanol crude extract at 200 mg/ml concentration in the disc diffusion test.](TOMICROJ-5-96_F2){#F2}

![The diagram demonstrates the growth inhibtion of the sensitive fungi expressed by log10 which detected by the microdilution assay after incubation with red cabbage (RC) methanol crude extract in different concentrations.](TOMICROJ-5-96_F3){#F3}

![The scanning electron microscope study of red cabbage methanol extract showing the cytological changes in *Staphylococcus aureus* ATCC 29247 cells: (**A**) control cells (**B**) treated cells and *Escherichia coli* ATCC 25922 cells: (**C**) control cells (**D**) treated cells.](TOMICROJ-5-96_F4){#F4}

![The transmission electron microscope study of red cabbage methanol extract showing the cytological changes in *Staphylococcus aureus* ATCC 29247 cells: (**A**) control cells: magnification 21.500k (**B**) treated cells: magnification 100.000k and *Escherichia coli* ATCC 25922 cells: (**C**) control cells: magnification 60.000k (**D**) treated cells: magnification 60.000k.](TOMICROJ-5-96_F5){#F5}

###### 

Antibacterial Activity of *B.oleracea* Methanol Extract by Disc diffusion Method

  Microorganisms                             Inhibition Zone in Diameter (mm)                                                               
  ------------------------------------------ ---------------------------------- ---------- ------------ ----------------------------------- ----------
  *Staphylococcus aureus*                    2 (clinical isolate)               \-         11.5 ± 2.5   \-[†](#T1F2){ref-type="table-fn"}   18 ± 0.4
  *S. aureus*                                1 (ATCC 29247 stain)               \-         11 ± 1.3     \-                                  17 ± 0.8
  MRSA[a](#T1F3){ref-type="table-fn"}        1 (clinical isolate)               \-         7 ± 0.5      \-                                  \-
  *Bacillus subtilis*                        1 (isolate)                        7 ± 0.3    17 ± 0.8     \-                                  18 ± 1.1
  *Escherichia coli*                         1(clinical isolate)                12 ± 0.9   19 ± 2.1     \-                                  16 ± 0.9
  *E.coli*                                   1 (ATCC 25922 strain)              15 ± 1.1   20 ± 1.0     \-                                  11 ± 0.3
  *E.coli*                                   1 (ATCC 35218 strain)              15 ± 0.8   20 ± 1.7     \-                                  16 ± 0.5
  *E.coli*O157:H7                            1 (isolate)                        13 ± 1.2   17 ± 0.4     \-                                  18 ± 0.8
  *Pseudomonas aeruginosa*                   1 (clinical isolate)               12 ± 0.6   19 ± 0.6     \-                                  18 ± 1.0
  *Klebsiella pneumoniae*                    1 (clinical isolate)               8 ± 0.5    15 ± 0.5     \-                                  19 ± 0.7
  *Salmonella enterica*serovar Typhimurium   1 (ATCC 25241 strain)              18 ± 1.3   18 ± 0.6     \-                                  15 ± 0.5

:MeOH: methanol

: (-) means no growth inhibition zone

Methicillin-resistant *Staphyloccocus aureus.*

###### 

The MIC and MBC Values Against the Tested Bacteria by the Microdilution Method

  Bacterial Species                           Number of Strains       MIC[\*](#T2F1){ref-type="table-fn"} (mg/ml)   MBC[†](#T2F2){ref-type="table-fn"} (mg/ml)   MBC: MIC Ratio   AntibacterialMode   Positive Control Streptomycinmg/ml   
  ------------------------------------------- ----------------------- --------------------------------------------- -------------------------------------------- ---------------- ------------------- ------------------------------------ -------
  *Staphylococcus aureus*                     2 (clinical isolate)    100                                           400                                          4: 1             Bacteristatic       0.065                                0.104
  *S. aureus*                                 1 (ATCC 29247 stain)    100                                           400                                          4: 1             Bacteristatic       0.06                                 0.1
  MRSA[a](#T2F3){ref-type="table-fn"}         1 (clinical isolate)    100                                           400                                          4: 1             Bacteristatic       \-[b](#T2F4){ref-type="table-fn"}    \-
  *Bacillus subtilis*                         1 (clinical isolate)    100                                           200                                          2: 1             Bactericidal        0.04                                 0.08
  *Escherichia coli*                          1(clinical isolate)     100                                           200                                          2: 1             Bactericidal        0.05                                 0.1
  *E.coli*                                    1 (ATCC 25922 strain)   100                                           400                                          4: 1             Bacteristatic       0.045                                0.09
  *E.coli*                                    1 (ATCC 35218 strain)   300                                           400                                          1.3: 1           Bactericidal        0.042                                0.08
  *E.coli* O157:H7                            1 (isolate)             200                                           400                                          2: 1             Bactericidal        0.049                                0.09
  *Pseudomonas aeruginosa*                    1 (clinical isolate)    100                                           200                                          2: 1             Bactericidal        0.047                                0.08
  *Klebsiella pneumoniae*                     1 (clinical isolate)    100                                           400                                          4: 1             Bacteristatic       0.05                                 0.085
  *Salmonella enterica* serovar Typhimurium   1 (ATCC 25241 strain)   400                                           500                                          1.25: 1          Bactericidal        0.048                                0.082

: minimum inhibitory concentration

: minimum bactericidal concentration

: Methicillin-resistant *Staphyloccocus aureus*

: (-) means no growth inhibition detected.

###### 

Antifungal Activity of *B.oleracea* Methanol Extract by Disc Diffusion Method

  Microorganisms                  Inhibition Zone in Diameter (mm)                                                             
  ------------------------------- ----------------------------------- ---- ---- ---------- ----------------------------------- ----------
  *Trichophyton rubrum*           1 (ATCC 11990)                      \-   \-   8 ± 0.3    \-[†](#T3F2){ref-type="table-fn"}   11 ± 0.5
  *Microsporum canis*             1 (ATCC 8137)                       \-   \-   \-         \-                                  10 ± 0.6
  *Aspergillus niger*             1  isolate                          \-   \-   \-         \-                                  18 ± 1.0
  *A.terreus*                     1 (ATCC strain 20542)               \-   10   11 ± 0.5   \-                                  10 ± 0.8
  *A.oryzae*                      1 isolate                           \-   \-   \-         \-                                  8 ± 0.6
  *Paecilomyces variotti*         1 isolate                           \-   \-   \-         \-                                  18 ± 1.0
  *Phanerochaete chrysosporium*   1 isolate                           \-   \-   \-         \-                                  19 ± 1.3
  *Trichoderma*sp.                1 isolate                           \-   \-   \-         \-                                  \-
  *Trichoderma*                   *harzianum* 1 (ATCC strain 20671)   \-   \-   \-         \-                                  10 ± 0.7
  *Trichoderma atroviride*        1 (ATCC strain 74058)               \-   \-   \-         \-                                  \-

MeOH: methanol

(-) means no growth inhibition zone.

###### 

The MIC and MFC Values Against the Tested Fungi by the Microdilution Method

  fungal Species          Number of Strains       MIC[\*](#T4F1){ref-type="table-fn"} (mg/ml)   MFC[†](#T4F2){ref-type="table-fn"} (mg/ml)   MFC: MICRatio   AntifungalMode   Positive Control Amphotericin Bµg/ml   
  ----------------------- ----------------------- --------------------------------------------- -------------------------------------------- --------------- ---------------- -------------------------------------- ---
  *Trichophyton rubrum*   1 (ATCC 11990)          75                                            300                                          4: 1            Fungistatic      2                                      3
  *Aspergillus terreus*   1 (ATCC strain 20542)   75                                            150                                          2: 1            Fungicidal       2.8                                    3

: minimum inhibitory concentration

: minimum fungicidal concentration.
